Bio-Techne Corporation (tech)
TECH Ownership
Institutional holdings, insider activity, and 13F data for Bio-Techne Corporation are premium features in Vest Terminal.
Ownership & insider analytics is available in Vest Terminal for Professional and Enterprise subscribers.
Start Free — open TECH in Vest Terminal
Access live data, filings, ownership, and analysis for Bio-Techne Corporation.
Bio-Techne Corporation FAQ
What does Bio-Techne Corporation (TECH) do?
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and…
What is TECH's P/E ratio?
Bio-Techne Corporation has a trailing P/E of 62.52× based on publicly available market data.
Does TECH pay a dividend?
Indicated dividend yield: 0.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is TECH in?
Bio-Techne Corporation is classified in Healthcare (Biotechnology) on NMS.
What is TECH's market capitalization?
Approximate market cap: $11.37B.
What are the main risks for TECH?
Key risks include above-average volatility (beta 1.27), elevated valuation, among factors on this page.
What are the strengths of TECH?
Potential positives include gross margin of 66.2% supports competitive unit economics, positive free cash flow ($229.65m).
Where can I get analyst estimates for TECH?
Public analyst price targets and consensus for Bio-Techne Corporation are on the free /stocks/tech/estimates page. Deeper estimate history and models are available in Vest Terminal.